Beloranib
Pharmacokinetics, Safety, Tolerability and Efficacy of Intravenous Doses of ZGN-433 in Obese Female Volunteers
Zafgen · Phase 1 · Completed · Enrollment 25
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Normal Saline | Obesity or overweight | n/r | n/r | n/r | n/r |
| ZGN-433 | Obesity or overweight | n/r | n/r | n/r | n/r |